PROVIDER PROFILE · NPI 1760650428

Melinda ConroyD.O.

DermatologyLakeway, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,644

Unique beneficiaries

—

Total services

2,961

Distinct HCPCS

Medicare payment

$139K

Peer benchmark

Total Medicare services vs. 965 Dermatology providers in TX — above median (cohort median 2,537).

PRESCRIBING · PART D · 2024

Total Rx claims

448

Beneficiaries

—

Total drug cost

$192K

Distinct drugs

Brand share

13.2%

Top prescribed drugs

Ketoconazole72 claims

Triamcinolone Acetonide69 claims

Clobetasol Propionate57 claims

Doxycycline Hyclate42 claims

Hydrocortisone40 claims

QUALITY · MIPS · 2024

Final MIPS score

75.0

Quality

0.0

Cost

0.0

Improvement activities

0.0

Promoting interop.

0.0

Payment adjustment

0.00%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$2K

Payment records

109

By payment type

Food and Beverage$2K

Education$95

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$22

REFERRAL NETWORK

Where Melinda Conroy's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Clinical Pathology Laboratories, Inc. Clinical Laboratory · Austin, TX	125	254
Daniel Freeland Family Practice · Lakeway, TX	13	37

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history